Arista Biologicals Revenue and Competitors
Estimated Revenue & Valuation
- Arista Biologicals's estimated annual revenue is currently $2.5M per year.
- Arista Biologicals's estimated revenue per employee is $155,000
Employee Data
- Arista Biologicals has 16 Employees.
- Arista Biologicals grew their employee count by 0% last year.
Arista Biologicals's People
Name | Title | Email/Phone |
---|
Arista Biologicals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Arista Biologicals?
Arista Biologicals is a leading manufacturer and supplier of rapid diagnostic reagents, components and related equipment for membrane-based assays. Reagents include colloidal gold conjugates, antigens, and antibodies used for assays such as fertility, drugs of abuse and infectious diseases. Our services include technical assistance, custom conjugations, antibody purification and assay development. We believe in formulating material of only the highest caliber, and guarantee the quality of each lot we create. Our mission is to combine innovation with success while continuing to provide the lowest possible prices to our clients. Our technical support team is available anytime to ensure and maintain the excellence of all our reagent and their finished products.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 16 | -64% | N/A |
#2 | $2.4M | 16 | 14% | N/A |
#3 | $1.5M | 17 | -6% | N/A |
#4 | N/A | 17 | -29% | N/A |
#5 | $2.1M | 17 | 13% | N/A |